BALATON,
Minn., Aug. 16, 2023 /PRNewswire/ --
The trū® Shrimp Companies, Inc. ("trū Shrimp")
announced today that trū Shrimp has appointed Hawkins, Inc.
("Hawkins") (NASDAQ: HWKN) as the exclusive distributor of its
trū® Chitosan products into the United States' pharmaceutical and medical
device industries.
trū Chitosan is derived from the exoskeletons of trū Shrimp's
production of consumer shrimp. Chitosan is a molecule refined from
the shell of shrimp and is used for numerous pharmaceutical and
medical applications. trū Shrimp is the only United States producer of chitosan that meets
the strict medical specifications of the United States
Pharmacopoeia – National Formulary (USP-NF) monograph.
"From our first introduction, we were impressed by the quality
standards set by trū Chitosan," said Chris
Meyer, Sales Manager of Hawkins Pharmaceutical. "Its trū
Chitosan products meet the quality and regulatory standards our
customer base demands."
"From the inception of trū Shrimp, we have pursued the
production of chitosan from the shells and peels of our shrimp,"
stated Michael Ziebell, President
and Chief Executive Officer of trū Shrimp. "trū Chitosan is the
result of the vision and work of our team and partners. We are
honored to have a company with the certifications and reputation of
Hawkins representing trū Chitosan to the medical industry."
The shrimp are grown indoors under controlled conditions free of
pollution, disease, preserving chemicals, and antibiotics. Those
same conditions ensure the quality and consistency of the shell
tissue raw material for the chitosan. These processes create an
unprecedented chain of custody from genetics to finished chitosan
which offers a precise and industry-unique Certificate of Origin
critical to medical applications. "Our pursuit of the world's
finest chitosan starts with the world's finest shrimp," added
Ziebell.
"We are excited to be able to provide trū Chitosan products to
our customer base," continued Meyer. "Chitosan is a heavily
researched biomaterial by the medical industry. Chitosan is a
versatile molecule with multiple uses including topical and
internal medicine as well as medical device applications."
About Hawkins, Inc.
Hawkins is a custom manufacturer and re-packager of high purity
production chemicals used in the pharmaceutical and biotech
industries. As a supply chain partner for the pharmaceutical and
biopharmaceutical industries, Hawkins offers a wide variety of
excipient production chemicals and support services.
About The trū Shrimp Companies, Inc.
trū Chitosan is a product of The trū Shrimp Companies, Inc., a
seafood and biopolymer company that produces premium consumer
shrimp, chitosan for medical applications made from its shrimp
shell tissue, and a high protein, low-fat pet food ingredient. From
its inception in 2014, the company has pioneered the development
and commercialization of a breakthrough, scalable and shallow water
indoor aquaculture platform that enables controlled, predictable
production of shrimp and shrimp shell tissue. The trū Shrimp
Companies' patented, proprietary Tidal Basin™ Technology was
engineered to ensure industry-leading food safety, supply chain
traceability, and measured and documented sustainability. Learn
more at www.trushrimp.com.
TRŪ SHRIMP CONTACT:
Jamie
Brink-Thordson
Director of Sales & Marketing
jamie.brinkthordson@trushrimp.com
View original
content:https://www.prnewswire.com/news-releases/the-tr-shrimp-companies-appoints-hawkins-as-exclusive-us-distributor-for-tr-chitosan-301902218.html
SOURCE The trū Shrimp Companies